Glucagen + Mayne Glucagon
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypoglycemia
Conditions
Hypoglycemia
Trial Timeline
Aug 1, 2007 → Mar 1, 2008
NCT ID
NCT00745186About Glucagen + Mayne Glucagon
Glucagen + Mayne Glucagon is a phase 1 stage product being developed by Pfizer for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT00745186. Target conditions include Hypoglycemia.
What happened to similar drugs?
2 of 14 similar drugs in Hypoglycemia were approved
Approved (2) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00745186 | Phase 1 | Completed |
Competing Products
20 competing products in Hypoglycemia